Sofinnova Investments, Inc. Ascendis Pharma A/S Transaction History
Sofinnova Investments, Inc.
- $1.8 Billion
- Q2 2024
A detailed history of Sofinnova Investments, Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 734,284 shares of ASND stock, worth $87.5 Million. This represents 5.56% of its overall portfolio holdings.
Number of Shares
734,284
Previous 754,032
2.62%
Holding current value
$87.5 Million
Previous $114 Million
12.15%
% of portfolio
5.56%
Previous 6.64%
Shares
12 transactions
Others Institutions Holding ASND
# of Institutions
223Shares Held
56.5MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.2 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$591 Million3.41% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.3MShares$512 Million0.93% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$500 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$467 Million0.29% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $6.65B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...